Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States.
J Med Econ
; 23(5): 442-447, 2020 May.
Article
in En
| MEDLINE
| ID: mdl-31928375
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Agents, Immunological
/
Squamous Cell Carcinoma of Head and Neck
/
Nivolumab
/
Head and Neck Neoplasms
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
J Med Econ
Journal subject:
SERVICOS DE SAUDE
Year:
2020
Document type:
Article
Affiliation country:
United States